Mostafa Kamal, CEO, Magellan Rx Management at MAGELLAN HEALTH INC (MGLN), sold 41,770 shares at $83.82 ($3.5M) on 2020-11-13, disclosed to the SEC on 2020-11-17.
Open-market sale of $3.5M MGLN by CEO, Magellan Rx Management. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $83.82 | 13,282 | $1.1M | 31.4% |
| 2 | $83.82 | 13,282 | $1.1M | 31.4% |
| 3 | $86.57 | 7,603 | $658K | 18.6% |
| 4 | $86.57 | 7,603 | $658K | 18.6% |
| Total | $84.82 avg | 41,770 | $3.5M | 100% |
| Filing → |
| MGLN | SELL | 2020-11-06 | $1.1M | — | Filing → |
| MGLN | SELL | 2020-10-20 | $15K | — | Filing → |
| MGLN | SELL | 2019-12-11 | $2.6M | — | Filing → |